Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients

NCT02281669 · clinicaltrials.gov ↗

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Cutaneous Leishmaniasis

Interventions

DRUG: Pentostam

Sponsor

Sheba Medical Center